Litigation Details for AstraZeneca AB v. Alembic Pharmaceuticals Ltd. (D. Del. 2022)
✉ Email this page to a colleague
AstraZeneca AB v. Alembic Pharmaceuticals Ltd. (D. Del. 2022)
Docket | ⤷ Sign Up | Date Filed | 2022-09-16 |
Court | District Court, D. Delaware | Date Terminated | 2022-12-30 |
Cause | 35:1 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 10,300,065 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AstraZeneca AB v. Alembic Pharmaceuticals Ltd.
Details for AstraZeneca AB v. Alembic Pharmaceuticals Ltd. (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2022-09-16 | 1 | Complaint | 22 Page 2 of 13 PageID #: 2 Patent No. 10,300,065 (“the ’065 patent”), that is listed in the Approved… This is an action for patent infringement arising under the patent laws of the United States, … PATENT-IN-SUIT 35. On May 28, 2019, the U.S. Patent and Trademark Office… the ’065 patent are valid and enforceable. AstraZeneca AB is the owner of the ’065 patent by assignment…Book-listed patents protecting BRILINTA® and its use, including the ’934 and ’065 patents. | External link to document |
2022-12-29 | 13 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,300,065. (Attachments: # 1… 30 December 2022 1:22-cv-01216 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |